Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
06/2005
06/09/2005US20050123633 Obtained by fermenting soybean germ, which is used as raw material, with koji mold, thus breaking down proteins, then hydrolyzing, extracting and concentrating using solvent to produce an isoflavone aglycone concentrate
06/09/2005US20050123609 Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
06/09/2005US20050123605 Anticancer agents; prevent forming blood vessels; removal blockage
06/09/2005US20050123558 Modifeid polypeptide
06/09/2005US20050123531 Administering to the individual therapeutically effective amount of human acid alpha-glucosidase at regular interval for therapy of glycogen storage disease type II
06/09/2005US20050123524 Pharmaceutical compositions and methods for treating neuronal damages and neurodegenerative diseases
06/09/2005US20050123512 Binding agents, vectors, host cells; gene therapy; nucleotide sequence with DNA insert encoding polypeptide; genetic engineering; medical diagnosis
06/09/2005DE102004054133A1 Silymarin-based food supplement for improving diet and reducing the risk of diseases of civilization, e.g. diabetes, contains a standardized flavonolignan fraction from Marian thistle and a dried Yacon root preparation
06/09/2005CA2547472A1 Cyclic amine derivative having heteroaryl ring
06/09/2005CA2547467A1 Piperidine compound and method for producing same
06/09/2005CA2547235A1 T-type calcium channel blocker
06/09/2005CA2547146A1 Diphenylamine derivatives
06/09/2005CA2547124A1 Tubular proteinuria as an indicator for elevated cardiovascular risk
06/09/2005CA2545192A1 Method of treatment of atherosclerosis
06/09/2005CA2538478A1 A pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases
06/09/2005CA2536181A1 Polymer compositions and methods for their use
06/08/2005EP1538207A1 Human antihuman mcp-1 antibody and antibody fragment thereof
06/08/2005EP1538202A2 Production of human alpha-galactosidase A
06/08/2005EP1538158A1 Proline ester and preparation containing the same for percutaneous administration
06/08/2005EP1537875A1 Preventive/remedy for arteriosclerosis
06/08/2005EP1537870A2 Methods and compositions for treating cancer
06/08/2005EP1537138A2 Receptors and membrane-associated proteins
06/08/2005EP1537129A1 Akt inhibitors, pharmaceutical compositions, and uses thereof
06/08/2005EP1537112A1 Condensed pyridines and pyrimidines with tie2 (tek) activity
06/08/2005EP1537108A1 Di and trifluoro-triazolo-pyridines anti-inflammatory compounds
06/08/2005EP1537106A1 Dihydropyrazolopyridine compounds
06/08/2005EP1537098A1 Monocyclic derivatives as matrix metalloproteinase inhibitors
06/08/2005EP1537096A2 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics
06/08/2005EP1537090A1 Chromone derivatives as matrix metalloproteinase inhibitors
06/08/2005EP1537087A1 Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same
06/08/2005EP1537086A2 Novel phenanthridines
06/08/2005EP1537084A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of
06/08/2005EP1537081A1 Dihydropyridine derivatives for use as human neutrophil elastase inhibitors
06/08/2005EP1537076A1 Novel vinyl carboxylic acid derivatives and their therapeutical use
06/08/2005EP1537075A2 Diarylurea derivatives and their use as chloride channel blockers
06/08/2005EP1537073A2 Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands
06/08/2005EP1536863A1 Use of cyclooxygenase-2 selective inhibitors and thrombolytic agents for the treatment or prevention of a vaso-occlusive event
06/08/2005EP1536835A1 Liquid formulations with high concentration of human growth hormone (hgh) comprising phenol
06/08/2005EP1536834A2 Design of chemokine analogs for the treatment of human diseases
06/08/2005EP1536817A1 Growth hormone-releasing peptides in the treatment of prevention of atherosclerosis and hypercholesterolemia
06/08/2005EP1536813A2 Compositions and methods comprising protein activated receptor antagonists
06/08/2005EP1536801A2 Topical compositions and methods for treatment of adverse effects of ionizing radiation
06/08/2005EP1536797A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related comounds as neurokinin-1 (nk-1) antagonsists for the treatment of emesis, depression, anxiety and cough
06/08/2005EP1536796A1 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion
06/08/2005EP1536778A2 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity
06/08/2005EP1536775A1 Compositions comprising hmg-coa reductase inhibitor
06/08/2005EP1536689A2 Gene therapy for critical limb ischemia with wild type or mutant enos
06/08/2005EP1465854A4 Chalcone derivatives and their use to treat diseases
06/08/2005EP1414937B1 Hops extracts, method for the production and use
06/08/2005EP1373269B1 Jun kinase inhibitors
06/08/2005EP1370528B1 Mch antagonists and their use in the treatment of obesity
06/08/2005EP1309575B1 Biphenyl derivatives and their use as ppar-gamma receptor activators
06/08/2005EP1268398B1 Novel method for synthesis of n- (s)-1-carboxybutyl]-(s)-alanine esters and use in synthesis of perindopril
06/08/2005EP1252133B1 Pharmaceutical compounds
06/08/2005EP1220831B1 Biaryl ether derivatives useful as monoamine reuptake inhibitors
06/08/2005EP1189895B1 Thiazole and oxazole derivatives and their pharmaceutical use
06/08/2005EP1176146B1 Carbamoyl tetrahydropyridine derivatives
06/08/2005EP1169441B1 Pharmaceutical compositions for the treatment of heart failure
06/08/2005EP1089735B1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists
06/08/2005EP1019045B1 Antithrombotic agents
06/08/2005EP1015459B1 Tetrazole-containing rapamycin analogs with shortened half-lives
06/08/2005EP1003501B9 Use of an agent for lowering the risk of cardiovascular disease
06/08/2005EP0983304B1 Dermatan disulfate, an inhibitor of thrombin generation and complement activation
06/08/2005EP0849256B1 Amide compounds and use of the same
06/08/2005CN1625603A Genetic polymorphisms in the preprotachykinin gene
06/08/2005CN1625597A Novel elongase gene and method for producing polyunsaturated fatty acids
06/08/2005CN1625559A Novel compounds that inhibit factor Xa activity
06/08/2005CN1625558A Aza-arylpiperazines
06/08/2005CN1625557A Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
06/08/2005CN1625556A Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions
06/08/2005CN1625555A Quinazoline compounds
06/08/2005CN1625554A Amides of aminoalkyl substituted azetidines, pyrrolidines, piperidines and azepanes
06/08/2005CN1625412A Aldosterone antagonist and non-steroidal anti-inflammatory agent combination therapy to prevent or treat cardiovascular disorders
06/08/2005CN1625406A Formulation containing (lyso-) phosphatidylserine for the prevention and treatment of stress states in warm-blooded animals
06/08/2005CN1625405A Combinations comprising cox-2 inhibitors and aspirin
06/08/2005CN1625404A Aldosterone receptor antagonist and alpha-adrenergic modulating agent combination therapy for prevention or treatment of cardiovascular conditions
06/08/2005CN1625398A A combination treatment for acute myocardial infarction
06/08/2005CN1625390A Multi-stage oral drug controlled-release system
06/08/2005CN1625338A Method for reducing calcified plaque buildup and cellular malfunction and for balancing ionic calcium
06/08/2005CN1624128A Death domain containing receptor 5 antibodies
06/08/2005CN1623994A New compound
06/08/2005CN1623992A Novel medicine of non peptide like angiotensin II receptor antagonism agent, their preparation and application
06/08/2005CN1623987A Novel processes for preparing torsemide
06/08/2005CN1623600A Inhibitor of angiotensin I transferase activity and its application
06/08/2005CN1623596A Mongolian medicine compound preparation for curing cardiac disease
06/08/2005CN1623593A Solid instant preparation extracted from ginkgo leaf and its preparing process
06/08/2005CN1623575A Haemorrhoid sclerosing agent injection
06/08/2005CN1623574A Injection for necrotizing therapy for baemorrhoids
06/08/2005CN1623555A Notoginseng saponin drops
06/08/2005CN1623547A Medical use of artificial lywrine
06/08/2005CN1623538A Tanshinone II A sulfonic acid or tanshinone II A sodium sulfonate freeze-dried powder injection and its preparation method
06/08/2005CN1623536A Preparation technology of isosorbide dinitrate injection
06/08/2005CN1623534A Use of creatine
06/08/2005CN1205220C Novel cyclosporins
06/08/2005CN1205216C Safflower lyochrome rich in carthamin A, its preparing process, its preparation containing them and its medical usage
06/08/2005CN1205205C Sodium-hydrogen exchanger type 1 inhibitor crystals
06/08/2005CN1205188C 4,5-dihydro-1h-pyrazole derivatives having CB1-antagonistic activity
06/08/2005CN1205186C ACE inhibitor nitric salts
06/08/2005CN1205185C Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
06/08/2005CN1205183C New amidino derivatives and their use as thrombin inhibitors
1 ... 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 ... 1595